Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in United States (AZD5851)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AZD5851
  • Duarte, California
  • +9 more
Oct 12, 2023

Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +10 more
  • Los Angeles, California
  • +4 more
Sep 5, 2023

Hepatocellular Carcinoma Trial in Worldwide (Budigalimab, Livmoniplimab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Prescott Valley, Arizona
  • +58 more
Apr 10, 2023

Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

Recruiting
  • Uterine Cervical Neoplasms
  • +10 more
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +11 more
  • Anchorage, Alaska
  • +65 more
Jan 27, 2023

l Science Network of Precision-based Immunotherapy for Primary

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
    • La Jolla, California
    • +6 more
    Jan 24, 2023

    Hepatocellular Carcinoma Trial in Chicago, New York (TheraSphere Y-90 glass microsphere therapy, Durvalumab (Imfinzi)

    Recruiting
    • Hepatocellular Carcinoma
    • TheraSphere Y-90 glass microsphere therapy
    • +2 more
    • Washington, District of Columbia
    • +7 more
    Jan 17, 2023

    Hepatocellular Carcinoma Trial in Worldwide (lenvatinib, pembrolizumab (200 mg))

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • San Francisco, California
    • +25 more
    Jan 13, 2023

    Hepatocellular Carcinoma, Liver Metastases, Cutaneous or Subcutaneous Lymph Node Trial in Worldwide (Talimogene Laherparepvec,

    Active, not recruiting
    Has Results
    • Hepatocellular Carcinoma
    • +3 more
    • Scottsdale, Arizona
    • +31 more
    Dec 7, 2022

    Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

    Completed
    Has Results
    • Multiple Myeloma
    • +6 more
    • Los Angeles, California
    • +15 more
    Dec 9, 2022

    Hepatocellular Carcinoma, Nonalcoholic Steatohepatitis Trial in Tarzana, New York, Durham (Lisinopril, Questionnaire

    Recruiting
    • Hepatocellular Carcinoma
    • Nonalcoholic Steatohepatitis
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +3 more
    Dec 8, 2022

    Hepatocellular Carcinoma Trial in Korea, Republic of, United States (SRF388, Atezolizumab, Bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Duarte, California
    • +17 more
    Dec 1, 2022

    Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

    Completed
    • Melanoma
    • +27 more
    • XmAb20717
    • Los Angeles, California
    • +16 more
    Nov 29, 2022

    Hepatocellular Carcinoma Trial in New York (SBRT, TACE)

    Completed
    • Hepatocellular Carcinoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Nov 22, 2022

    Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +11 more
    • Part 1 TPST-1120
    • +3 more
    • San Francisco, California
    • +10 more
    Nov 1, 2022

    Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

    Active, not recruiting
    • Oesophageal Squamous Cell Carcinoma
    • +4 more
    • Duarte, California
    • +39 more
    Oct 31, 2022

    Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Intrahepatic Cholangiocarcinoma
    • New York, New York
    • +3 more
    Oct 19, 2022

    Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

    Recruiting
    • Breast Cancer
    • +15 more
    • ATRC-101
    • +2 more
    • Phoenix, Arizona
    • +10 more
    Sep 28, 2022

    Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma Trial in United States (Cisplatin, Doxorubicin Hydrochloride,

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Unresectable Hepatocellular Carcinoma
    • Birmingham, Alabama
    • +280 more
    Sep 23, 2022

    Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Bevacizumab, Placebo)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Birmingham, Alabama
    • +213 more
    Aug 19, 2022

    Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

    Terminated
    • Pancreatic Adenocarcinoma
    • +13 more
    • San Francisco, California
    • +7 more
    Aug 17, 2022

    Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Duarte, California
    • +22 more
    Aug 17, 2022

    AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

    Recruiting
    • AIDS-Related Non-Hodgkin Lymphoma
    • +29 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Birmingham, Alabama
    • +12 more
    Aug 4, 2022

    Utilization of MAsS in Patients Undergoing LT for HCC

    Recruiting
    • NAFLD
    • +5 more
      • New York, New York
        Columbia University Irving Medical Center
      Jun 29, 2022

      Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

      Recruiting
      • Ovarian Cancer
      • +10 more
      • West Hollywood, California
      • +27 more
      Jun 27, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Tremelimumab, Durvalumab, Bevacizumab)

      Active, not recruiting
      Has Results
      • Hepatocellular Carcinoma
      • Tremelimumab
      • +2 more
      • Phoenix, Arizona
      • +43 more
      Jun 22, 2022